134 related articles for article (PubMed ID: 3109145)
1. Treatment and course of erythema chronicum migrans.
Neumann R; Aberer E; Stanek G
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):372-6. PubMed ID: 3109145
[TBL] [Abstract][Full Text] [Related]
2. Microbiological findings in erythema (chronicum) migrans and related disorders.
Neubert U; Krampitz HE; Engl H
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):237-52. PubMed ID: 3577483
[TBL] [Abstract][Full Text] [Related]
3. Therapy of Lyme borreliosis in children.
Krbkova L; Stanek G
Infection; 1996; 24(2):170-3. PubMed ID: 8740116
[TBL] [Abstract][Full Text] [Related]
4. Treating erythema chronicum migrans of Lyme disease.
Berger BW
J Am Acad Dermatol; 1986 Sep; 15(3):459-63. PubMed ID: 3093544
[TBL] [Abstract][Full Text] [Related]
5. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays.
Asbrink E; Hovmark A; Hederstedt B
Acta Derm Venereol; 1985; 65(6):509-14. PubMed ID: 2420115
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
7. Evidence for spirochetal origin of circumscribed scleroderma (morphea).
Aberer E; Stanek G; Ertl M; Neumann R
Acta Derm Venereol; 1987; 67(3):225-31. PubMed ID: 2442935
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans.
Weber K; Preac-Mursic V; Neubert U; Thurmayr R; Herzer P; Wilske B; Schierz G; Marget W
Ann N Y Acad Sci; 1988; 539():324-45. PubMed ID: 3056202
[TBL] [Abstract][Full Text] [Related]
9. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans.
Hansen K; Hovmark A; Lebech AM; Lebech K; Olsson I; Halkier-Sørensen L; Olsson E; Asbrink E
Acta Derm Venereol; 1992 Aug; 72(4):297-300. PubMed ID: 1357894
[TBL] [Abstract][Full Text] [Related]
10. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
[TBL] [Abstract][Full Text] [Related]
11. Early detection and persistence of antibodies to Borrelia burgdorferi in persons with Lyme disease.
Magnarelli LA; Anderson JF
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Feb; 263(3):392-9. PubMed ID: 3296563
[TBL] [Abstract][Full Text] [Related]
12. [Neurologic manifestations of Borrelia burgdorferi infections].
Uldry PA; Steck AJ; Regli F
Schweiz Med Wochenschr; 1986 Feb; 116(5):135-42. PubMed ID: 3961463
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.
Arnez M; Radsel-Medvescek A; Pleterski-Rigler D; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 1999 Dec; 111(22-23):916-22. PubMed ID: 10666802
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi.
Magnarelli LA; Anderson JF
Am J Epidemiol; 1988 Apr; 127(4):818-25. PubMed ID: 3354546
[TBL] [Abstract][Full Text] [Related]
15. [Borrelia infections of the skin--progress of knowledge since the discovery of Lyme disease].
Garbe C
Hautarzt; 1991 Jun; 42(6):356-65. PubMed ID: 1917458
[TBL] [Abstract][Full Text] [Related]
16. [Erythema migrans. The clinical spectrum of Borrelia burgdorferi infection].
Satz N; Ott A; Zogg F; Knoblauch M
Schweiz Med Wochenschr; 1986 Jun; 116(23):763-9. PubMed ID: 3726507
[TBL] [Abstract][Full Text] [Related]
17. IgM rheumatoid factor in Lyme disease: correlation with disease activity, total serum IgM, and IgM antibody to Borrelia burgdorferi.
Kujala GA; Steere AC; Davis JS
J Rheumatol; 1987 Aug; 14(4):772-6. PubMed ID: 3668982
[TBL] [Abstract][Full Text] [Related]
18. Erythema migrans: three weeks treatment for prevention of late Lyme borreliosis.
Breier F; Kunz G; Klade H; Stanek G; Aberer E
Infection; 1996; 24(1):69-72. PubMed ID: 8852474
[TBL] [Abstract][Full Text] [Related]
19. [First report of three culture confirmed human Lyme cases in Turkey].
Polat E; Turhan V; Aslan M; Müsellim B; Onem Y; Ertuğrul B
Mikrobiyol Bul; 2010 Jan; 44(1):133-9. PubMed ID: 20455410
[TBL] [Abstract][Full Text] [Related]
20. [Livedo racemosa: an unusual late manifestation of borreliosis?].
Baumann M; Tebbe B; Arnold M; Krengel S; Goerdt S; Orfanos CE
Hautarzt; 2000 Aug; 51(8):593-6. PubMed ID: 10997315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
